Pharmaceutical

AstraZeneca completes Fusion Pharmaceuticals acquisition

AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.

Jun 6, 2024 - 04:00
AstraZeneca completes Fusion Pharmaceuticals acquisition
AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.
Read the original article

Tags:

Previous Article

J&J seeks expanded approvals for paediatric HIV-1 therapy

Next Article

Climate change may aggravate multiple sclerosis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: I’m a biopharma supply chain specialist — and even I can’t find the Adderall I’m prescribed

Opinion: I’m a biopharma supply chain specialist — and ...

Apr 15, 2023

Cidara to continue its CD388 influenza programme despite Janssen’s contrary decision

Cidara to continue its CD388 influenza programme despit...

Jul 21, 2023

STAT+: Novo says oral version of Ozempic leads to 15% weight loss

STAT+: Novo says oral version of Ozempic leads to 15% w...

May 23, 2023